Announcing the 2024 Award Recipients for Humanitarianism, Distinguished Faculty, and Volunteer of the Year Statement from Dr. Binay Shah The Binaytara Foundation (BTF) is a global cancer non-profit dedicated to
An Equity and Social Justice Opportunity By Dr. Richa Parikh In this talk, Dr. Nadine J. Barrett discusses the effects of implicit bias among physicians on patients. A study reporting results
MorePresenter: Mariana Socal, MD, PhD Author: Ronan Hsieh, MD, MS Drug shortage has become a challenging problem in the field of oncology. Drugs that are particularly at risk for shortage include
MoreDealing with decades of drug shortages Presenter: Karen Hagerty, MD Author: Ronan Hsieh, MD, MS “Cancer drug shortages continue to be a crisis for cancer care.”, said Dr. Karen Hagerty during
MoreBy Dr. Kelly Meza In Moffitt Cancer Center’s catchment area, the Hispanic population predominates, with most residents originating from Puerto Rico, Mexico, and South American countries. However, language barriers persist, with
MorePrimary Care Partnership to Improve Comprehensive Survivorship Care By Dr. Kelly Meza OPTIMISE, the Oncology Primary Care Partnership to Improve Comprehensive Survivorship Care, leads the charge in tackling cancer disparities and
MoreListening to the Community to Fuel Outreach and Engagement By Dr. Kelly Meza Dr. Ramirez and her team at Mays Cancer Center are dedicated to tackling the unequal impact of cancer
MorePresented by: Dr. Stephen S. Grubbs As we look at quality through value-based solutions, there are many perspectives to explore and to integrate. Our professional society, the American Society of Clinical
MoreReported Data During Cancer Chemotherapy Course Using LSTM Modeling By Joseph Finkelstein, Aref Smiley, Christina Echeverria, Kathi Mooney Dept. Biomedical Informatics and College of Nursing, The University of Utah The paper
MoreClinical trials are the process by which progress is made in clinical care. It is accepted and understood that participants in clinical trials must be assessed for both toxicity and efficacy, but
MoreBy Dr. Brenda Santellano – Research Associate at Georgia Cancer Center Dr. Finkelstein explored the transformative role of artificial intelligence (AI) in cancer care, outlining its applications across cancer care and
More